Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes

L. Galgóczy, Gyöngyi Lukács, Ildikó Nyilasi, T. Papp, C. Vágvölgyi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The in vitro antifungal activity of different statins and the combinations of the two most effective ones (fluvastatin and rosuvastatin) with amphotericin B were investigated in this study on 6 fungal isolates representing 4 clinically important genera, namely Absidia, Rhizomucor, Rhizopus and Syncephalastrum . The antifungal effects of statins revealed substantial differences. The synthetic statins proved to be more effective than the fungal metabolites. All investigated strains proved to be sensitive to fluvastatin. Fluvastatin and rosuvastatin acted synergistically and additively with amphotericin B in inhibiting the fungal growth in clinically available concentration ranges. Results suggest that statins combined with amphotericin B have a therapeutic potential against fungal infections caused by Zygomycetes species.

Original languageEnglish
Pages (from-to)356-365
Number of pages10
JournalActa Biologica Hungarica
Volume61
Issue number3
DOIs
Publication statusPublished - Sep 1 2010

Fingerprint

fluvastatin
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Amphotericin B
metabolite
Absidia
Rhizomucor
Rhizopus
Mycoses
Metabolites
effect
infection
Growth

Keywords

  • amphotericin B
  • drug interaction
  • Statin
  • synergism
  • Zygomycetes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Environmental Science(all)
  • Neurology
  • Medicine(all)

Cite this

Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes. / Galgóczy, L.; Lukács, Gyöngyi; Nyilasi, Ildikó; Papp, T.; Vágvölgyi, C.

In: Acta Biologica Hungarica, Vol. 61, No. 3, 01.09.2010, p. 356-365.

Research output: Contribution to journalArticle

@article{3eec973873d64b1781cbe0a8a17ad322,
title = "Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes",
abstract = "The in vitro antifungal activity of different statins and the combinations of the two most effective ones (fluvastatin and rosuvastatin) with amphotericin B were investigated in this study on 6 fungal isolates representing 4 clinically important genera, namely Absidia, Rhizomucor, Rhizopus and Syncephalastrum . The antifungal effects of statins revealed substantial differences. The synthetic statins proved to be more effective than the fungal metabolites. All investigated strains proved to be sensitive to fluvastatin. Fluvastatin and rosuvastatin acted synergistically and additively with amphotericin B in inhibiting the fungal growth in clinically available concentration ranges. Results suggest that statins combined with amphotericin B have a therapeutic potential against fungal infections caused by Zygomycetes species.",
keywords = "amphotericin B, drug interaction, Statin, synergism, Zygomycetes",
author = "L. Galg{\'o}czy and Gy{\"o}ngyi Luk{\'a}cs and Ildik{\'o} Nyilasi and T. Papp and C. V{\'a}gv{\"o}lgyi",
year = "2010",
month = "9",
day = "1",
doi = "10.1556/ABiol.61.2010.3.11",
language = "English",
volume = "61",
pages = "356--365",
journal = "Acta Biologica Hungarica",
issn = "0236-5383",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes

AU - Galgóczy, L.

AU - Lukács, Gyöngyi

AU - Nyilasi, Ildikó

AU - Papp, T.

AU - Vágvölgyi, C.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - The in vitro antifungal activity of different statins and the combinations of the two most effective ones (fluvastatin and rosuvastatin) with amphotericin B were investigated in this study on 6 fungal isolates representing 4 clinically important genera, namely Absidia, Rhizomucor, Rhizopus and Syncephalastrum . The antifungal effects of statins revealed substantial differences. The synthetic statins proved to be more effective than the fungal metabolites. All investigated strains proved to be sensitive to fluvastatin. Fluvastatin and rosuvastatin acted synergistically and additively with amphotericin B in inhibiting the fungal growth in clinically available concentration ranges. Results suggest that statins combined with amphotericin B have a therapeutic potential against fungal infections caused by Zygomycetes species.

AB - The in vitro antifungal activity of different statins and the combinations of the two most effective ones (fluvastatin and rosuvastatin) with amphotericin B were investigated in this study on 6 fungal isolates representing 4 clinically important genera, namely Absidia, Rhizomucor, Rhizopus and Syncephalastrum . The antifungal effects of statins revealed substantial differences. The synthetic statins proved to be more effective than the fungal metabolites. All investigated strains proved to be sensitive to fluvastatin. Fluvastatin and rosuvastatin acted synergistically and additively with amphotericin B in inhibiting the fungal growth in clinically available concentration ranges. Results suggest that statins combined with amphotericin B have a therapeutic potential against fungal infections caused by Zygomycetes species.

KW - amphotericin B

KW - drug interaction

KW - Statin

KW - synergism

KW - Zygomycetes

UR - http://www.scopus.com/inward/record.url?scp=77956013208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956013208&partnerID=8YFLogxK

U2 - 10.1556/ABiol.61.2010.3.11

DO - 10.1556/ABiol.61.2010.3.11

M3 - Article

C2 - 20724281

AN - SCOPUS:77956013208

VL - 61

SP - 356

EP - 365

JO - Acta Biologica Hungarica

JF - Acta Biologica Hungarica

SN - 0236-5383

IS - 3

ER -